Aurora Cannabis (ACB) vs Canopy Growth (CGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Canopy Growth (CGC) over the past year, losing 27.7% versus a loss of 39.6%. Over five years, ACB leads with a -93.7% price change compared with -99.3% for CGC. Canopy Growth is the larger company by market cap ($393.8 million vs $282.4 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | CGC |
|---|---|---|
| Share price | $4.46 | $0.8765 |
| Market cap | $282.36M | $393.81M |
| 1-day change | -2.83% | -1.59% |
| YTD return | +5.69% | -23.11% |
| 1-year return | -27.71% | -39.55% |
| 5-year return | -93.66% | -99.34% |
| EPS (TTM) | $-0.61 | $-0.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $2.38 |
| 52-week low | $2.56 | $0.844 |
| Distance from 52-week high | -33.08% | -63.17% |
| Analyst consensus | buy | none |
| Avg. price target upside | — | +35.77% |
| Average volume | 1.36M | 2.77M |
| Shares outstanding | 63.31M | 423.04M |
| Employees | 1,028 | 1,128 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACB has outperformed CGC by 11.8 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Canopy Growth
CGC stock →Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,128 employees
ACB vs CGC FAQ
Which is bigger, Aurora Cannabis or Canopy Growth?
Canopy Growth (CGC) is larger, with a market capitalization of $393.81M compared with $282.36M for Aurora Cannabis (ACB).
Which stock has performed better over the past year, ACB or CGC?
ACB returned -27.71% over the past 12 months, compared with -39.55% for CGC (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Canopy Growth in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.